Clicky

Enfusion, Inc.(ENFN)

Description: Enfusion Inc. offers software-as-a-service for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.


Keywords: Investment Management Fundamental Analysis Portfolio Manager

Home Page: www.enfusion.com

ENFN Technical Analysis

125 South Clark Street
Chicago, IL 60603
United States
Phone: 312 253 9800


Officers

Name Title
Mr. Oleg Movchan Interim CEO & Director
Mr. Stephen Malherbe Managing Partner
Mr. Stephen P. Dorton Chief Financial Officer
Mr. Michael Berry Chief Operating Officer
Mr. Daniel Groman Chief Technology Officer
Mr. Brian Murphy Investor
Ms. Lorelei M. Skillman Chief Marketing & Communications Officer
Ms. Bronwen Bastone Chief People Officer
Mr. Kabir Kohli MD of Managed Services Solutioning & Global Head of Client Services
Mr. Joseph Defeo Global Head of Managed Services Production

Exchange: NYSE

Country: US

Currency: US Dollar ($)

Forward PE: 67.1141
Trailing PE: 0
Price-to-Book MRQ: 10.7775
Price-to-Sales TTM: 4.533
IPO Date: 2021-10-21
Fiscal Year End: December
Full Time Employees: 892
Back to stocks